Sorry, you need to enable JavaScript to visit this website.

Pfizer supports the global healthcare community’s independent initiatives (e.g., research, quality improvement or education) to improve patient outcomes in areas of unmet medical need that are aligned with Pfizer’s medical and/or scientific strategies.

Pfizer’s competitive grant program involves a publicly posted Request for Proposal (RFP) that provides detail regarding a specific area of interest and sets timelines for review and approval. Organizations are invited to submit an application addressing the specific gaps in research, practice or care as outlined in the specific RFP. The grant requester (and ultimately the grantee) is responsible for the design, implementation, sponsorship, and conduct of the independent initiative supported by the grant, including compliance with any regulatory requirements.

Sign-up to receive all GMG announcements, including Request for Proposal (RFP) postings.

Sign Up for Alerts Details
  • Title
    Grant Type
    Focus Area
    Country
    Application Due Date
    The Value of axitinib in combination with Immuno-oncology (IO) in Patients with Metastatic Renal Cell Carcinoma (mRCC)
    Release Date:
    Review Process: Pfizer Internal
    Research Oncology China
    Innovative Digital Health Projects to increase the Quality of Life (QoL) of Multiple Myeloma (MM) patients
    Release Date:
    Review Process: Expert Review Panel
    Quality Improvement Oncology Italy
    2024 RD Global Monitoring anti-TFPI RES
    Release Date:
    Review Process: Pfizer Internal
    Research Rare Disease All
    Call for Independent Medical Education Grant Applications Oncology – Urothelial Carcinoma (UC)
    Release Date:
    Partner: Astellas
    Review Process: Pfizer Internal
    Education Oncology All
    Health Services Research to Improve Management of mBC Patients Treated with Tucatinib
    Release Date:
    Review Process: Pfizer Internal
    Research Oncology All
    Addressing Multiple Myeloma Gaps in Care for Patients in Latin America
    Release Date:
    Partner: International Myeloma Foundation
    Review Process: Expert Review Panel
    Education Oncology Argentina, Brazil, Colombia, Mexico
    Providing Appropriate Medical Care for IBD Patients
    Release Date:
    Partner: Japanese Society for Inflammatory Bowel Disease (JSIBD)
    Review Process: Expert Review Panel
    Translation: Japanese (link)
    Quality Improvement Inflammation & Immunology Japan
    Management of Atopic Dermatitis / Alopecia Areata
    Release Date:
    Review Process: Pfizer Internal
    Education Inflammation & Immunology USA
  • Title
    Grant Type
    Focus Area
    Country
    Application Due Date
    Rheumatology Education Healthcare Disparities
    Release Date:
    Review Process: Pfizer Internal
    Education Inflammation & Immunology USA
    Promotion of the Appropriate Diagnosis and Treatment of Overactive Bladder or Neurogenic Bladder
    Release Date:
    Review Process: Pfizer Internal
    Education Internal Medicine Japan
    Improving Knowledge and Capability to Communicate Information on the Latest Hemophilia Treatments
    Release Date:
    Review Process: Pfizer Internal
    Education Rare Disease Japan
    Equity in Access to Cancer Cachexia Clinical Trials
    Release Date:
    Review Process: Pfizer Internal
    Quality Improvement Internal Medicine All
    Infectious Disease Fellowship
    Release Date:
    Review Process: Expert Review Panel
    Fellowship Hospital India
    Inflammatory Bowel Disease (Europe, Canada, Australia, New Zealand, Japan, Israel and Turkey)
    Release Date:
    Review Process: Expert Review Panel
    Fellowship Inflammation & Immunology All
    Raising Awareness and Promoting Timely Diagnosis of TTR Amyloidosis
    Release Date:
    Partner: Mayo Clinic
    Review Process: Expert Review Panel
    Translation: Arabic (link)
    Translation: French (link)
    Translation: Mandarin (link)
    Translation: Spanish (link)
    Quality Improvement Rare Disease All
    2022 Growth Hormone Research
    Release Date:
    Review Process: Pfizer Internal
    Research Rare Disease All
    Meta-analysis of COVID-19 Vaccine Hesitancy Behavioral & Social Science Research
    Release Date:
    Review Process: Pfizer Internal
    Research Vaccines USA
    New & Emerging Therapies for Atopic Dermatitis for Dermatologists, Allergists, and Advanced Practice Providers
    Release Date:
    Review Process: Pfizer Internal
    Education Inflammation & Immunology USA
    Addressing the Needs of Patients with Mental Health Issues and Inflammatory Bowel Diseases
    Release Date:
    Review Process: Pfizer Internal
    Quality Improvement Inflammation & Immunology Canada
    Improving the Care of Patients with Disorders of Impaired Growth
    Release Date:
    Partner: ICOSEP
    Review Process: Expert Review Panel
    Quality Improvement Rare Disease All